7-92066518-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005751.5(AKAP9):c.6302A>G(p.Gln2101Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,613,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP9 | NM_005751.5 | c.6302A>G | p.Gln2101Arg | missense_variant | Exon 26 of 50 | ENST00000356239.8 | NP_005742.4 | |
AKAP9 | NM_147185.3 | c.6302A>G | p.Gln2101Arg | missense_variant | Exon 26 of 50 | NP_671714.1 | ||
AKAP9 | NM_001379277.1 | c.947A>G | p.Gln316Arg | missense_variant | Exon 5 of 29 | NP_001366206.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250618Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135426
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461210Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726922
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74386
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 2101 of the AKAP9 protein (p.Gln2101Arg). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with AKAP9-related conditions. ClinVar contains an entry for this variant (Variation ID: 526982). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.Q2101R variant (also known as c.6302A>G), located in coding exon 26 of the AKAP9 gene, results from an A to G substitution at nucleotide position 6302. The glutamine at codon 2101 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at